Premium
Targeted and multiplexed quantitation of CSF proteins by MRM and labeled peptide standards (981.5)
Author(s) -
Percy Andrew,
Chambers Andrew,
Yang Juncong,
Hardie Darryl,
Borchers Christoph
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.981.5
Subject(s) - biomarker , biomarker discovery , cerebrospinal fluid , quantitative proteomics , triple quadrupole mass spectrometer , computational biology , reproducibility , chemistry , chromatography , proteomics , selected reaction monitoring , mass spectrometry , medicine , biology , pathology , tandem mass spectrometry , biochemistry , gene
Precise and accurate protein quantitation is essential for screening biomarkers for risk stratification, disease prognostication, and therapeutic monitoring. The most promising analytical strategy for quantitating unverified biomarkers in pre‐clinical biofluids relies on targeted MRM/MS with isotopically labeled standards. Through this approach, considerable effort has been extended toward verifying protein biomarkers of non‐communicable disease in the systematic circulation, but little in the way of accelerating the discovered markers of central nervous system‐related diseases in cerebrospinal fluid (CSF). We herein aimed to develop a rapid and robust, antibody‐free method to quantify a large panel of proteins in human CSF for disease biomarker verification and validation studies. Using pooled CSF and a complex isotopically coded peptide mixture, various denaturation/digestion approaches were evaluated within a bottom‐up proteomic workflow. For enhanced reproducibility and multiplexing, peptides were separated at standard‐flow rates and detected by dynamic MRM in a triple quadrupole mass spectrometer. The final method demonstrated excellent reproducibility (average retention times of 0.06% and signal of 5.8% CV) and enabled the quantitation of 155 protein biomarker candidates (inferred from 337 interference‐free peptides) in a 43 min run. The quantitative analyses of >100 CSF samples from spinal cord injury patients is currently being performed and will additionally be presented. Grant Funding Source : Supported by Genome BC, Genome Canada, and the Western Economic Diversification of Canada.